Profile
| Metric | Value |
|---|---|
| Full Name | Bristol-Myers Squibb Company |
| Ticker | NYSE: BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bms.com |
| Employees | 34,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $55.26 | |
| Price, 1D Change | -2.40% | |
| Market Cap | $112B | |
| TTM Dividend Yield | 4.51% | |
| PE Ratio | 18.66 | |
| Beta | 0.31 | |
| Revenue | $48B | |
| Revenue, 1Y Change | +7.32% | |
| EPS | -$4.41 | |
| EPS, 1Y Change | -214.31% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.63 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1000000:951777 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$4.41 | |
| EPS Estimate | $6.44 | |
| EPS Est. Change | +245.79% | |
| Revenue | $48.30B | |
| Revenue Estimate | $47.97B | |
| Revenue Est. Change | -0.68% | |
| Current Price | $55.26 | |
| Price Target | - | $58.00 |
| Price Tgt. Change | - | +4.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.39 | $3.86 | -47.74% | |
| $0.92 | -$4.41 | -580.82% | |
| $6.44 | N/A | +245.79% | |
| $6.00 | N/A | +235.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $44.71B | $45.01B | +0.66% | |
| $47.51B | $48.30B | +1.66% | |
| $47.97B | N/A | -0.68% | |
| $44.11B | N/A | -8.67% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -1.99% | |
| Price, 3Y | -23.79% | |
| Market Cap, 1Y | -1.66% | |
| Market Cap, 3Y | -25.23% | |
| Revenue, 1Y | +7.32% | |
| Revenue, 3Y | +4.13% | |
| EPS, 1Y | -214.31% | |
| EPS, 3Y | -241.70% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $55.26 | |
| SMA 200 | $48.31 | |
| SMA 200 vs Price | -12.58% | |
| SMA 50 | $51.54 | |
| SMA 50 vs Price | -6.73% | |
| Beta | 0.31 | |
| ATR | $1.22 | |
| 14-Day RSI | 56.91 | |
| 10-Day Volatility | 31.75% | |
| 1-Year Volatility | 29.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.63 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 4.34% | |
| Total Dividend | $2.40 | |
| Dividends Paid | $4.86B | |
| Payout Ratio | -54.44% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $48.30B | |
| EPS | -$4.41 | |
| Gross Profit | $27.43B | |
| Gross Margin | 56.80% | |
| Operating Profit | $9.66B | |
| Operating Margin | -23.21% | |
| Net Income | -$8.93B | |
| Net Margin | -18.49% | |
| EBITDA | $19.31B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 3.13 | |
| Current Ratio | 1.25 | |
| Quick Ratio | 1.15 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.05 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 18.66 | |
| PS Ratio | 2.34 | |
| PB Ratio | 6.06 | |
| EV/EBITDA | 7.75 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $16.33B | |
| Cash & Equivalents | $10.86B | |
| Total Assets | $92.60B | |
| Current Assets | $29.78B | |
| Total Liabilities | $76.22B | |
| Current Liabilities | $23.77B | |
| Total Debt | $51.20B | |
| Short Term Debt | $2.23B | |
| Accounts Payable | $3.60B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $57.25B | |
| Operating Expenses | $17.77B | |
| Cost Of Goods Sold | $20.87B | |
| SG&A | $0.00 | |
| D&A | $9.60B | |
| Interest Expense | $0.00 | |
| Income Tax | $554.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $15.19B | |
| CFI | -$21.35B | |
| CFF | $5.13B | |
| Capex | $1.25B | |
| Free Cash Flow | $13.94B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Scotiabank | → | |
| UBS | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| Scotiabank | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with BMY
FAQ
What is the ticker symbol for Bristol-Myers Squibb Company?
The ticker symbol for Bristol-Myers Squibb Company is NYSE:BMY
Does Bristol-Myers Squibb Company pay dividends?
Yes, Bristol-Myers Squibb Company pays dividends. The last payment was $0.63, with an ex-dividend date on January 2, 2026
What sector is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the Healthcare sector
What industry is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the General Drug Manufacturers industry
What country is Bristol-Myers Squibb Company based in?
Bristol-Myers Squibb Company is headquartered in United States
When did Bristol-Myers Squibb Company go public?
Bristol-Myers Squibb Company initial public offering (IPO) was on June 1, 1972
Is Bristol-Myers Squibb Company in the S&P 500?
Yes, Bristol-Myers Squibb Company is included in the S&P 500 index
Is Bristol-Myers Squibb Company in the NASDAQ 100?
No, Bristol-Myers Squibb Company is not included in the NASDAQ 100 index
Is Bristol-Myers Squibb Company in the Dow Jones?
No, Bristol-Myers Squibb Company is not included in the Dow Jones index
When was Bristol-Myers Squibb Company last earnings report?
Bristol-Myers Squibb Company's most recent earnings report was on October 30, 2025
When does Bristol-Myers Squibb Company report earnings?
The next expected earnings date for Bristol-Myers Squibb Company is February 5, 2026
Data Sources & References
- BMY Official Website www.bms.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BMY Profile on Yahoo Finance finance.yahoo.com/quote/BMY
- BMY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmy
